Tony Lahoutte
Brussels, BRU, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 93 publications
Pharmacokinetics and dosimetry of radiolabeled FAP-targeting single-domain antibody 4AH29 in Göttingen minipigs.
Journal: Nuclear medicine and biology
Published: February 27, 2026
Preclinical synergistic effects when combining a radiolabelled HER2-targeting single domain antibody with PARP inhibitor Olaparib.
Journal: Journal of translational medicine
Published: September 17, 2025
Immune modulation following α and β- radionuclide therapy targeting fibroblast activation protein-α in a preclinical tumor model.
Journal: Oncoimmunology
Published: August 01, 2025
Automated radiofluorination of HER2 single domain antibody: the road towards the clinical translation of [18F]FB-HER2 sdAb.
Journal: EJNMMI radiopharmacy and chemistry
Published: September 08, 2024
Efficient α and β- radionuclide therapy targeting fibroblast activation protein-α in an aggressive preclinical mouse tumour model.
Journal: European journal of nuclear medicine and molecular imaging
Published: June 28, 2024
Generic semi-automated radiofluorination strategy for single domain antibodies: [18F]FB-labelled single domain antibodies for PET imaging of fibroblast activation protein-α or folate receptor-α overexpression in cancer.
Journal: EJNMMI radiopharmacy and chemistry
Published: June 12, 2024
Development and evaluation of a single domain antibody targeting folate receptor alpha for radioligand therapy.
Journal: Journal of nanobiotechnology
Published: June 03, 2024
Optimizing the Therapeutic Index of sdAb-Based Radiopharmaceuticals Using Pretargeting.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: February 16, 2024
Preclinical Evaluation of a Radiotheranostic Single-Domain Antibody Against Fibroblast Activation Protein α.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: July 17, 2023
Phase II Trial Assessing the Repeatability and Tumor Uptake of [68Ga]Ga-HER2 Single-Domain Antibody PET/CT in Patients with Breast Carcinoma.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: July 05, 2023
Phase I Study of [68Ga]Ga-Anti-CD206-sdAb for PET/CT Assessment of Protumorigenic Macrophage Presence in Solid Tumors (MMR Phase I).
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: October 24, 2022
Preclinical Evaluation of 225Ac-Labeled Single-Domain Antibody for the Treatment of HER2pos Cancer.
Journal: Molecular cancer therapeutics
Published: December 21, 2021
Last Updated: 09/26/2026